KR101816617B1 - Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof - Google Patents
Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof Download PDFInfo
- Publication number
- KR101816617B1 KR101816617B1 KR1020150190998A KR20150190998A KR101816617B1 KR 101816617 B1 KR101816617 B1 KR 101816617B1 KR 1020150190998 A KR1020150190998 A KR 1020150190998A KR 20150190998 A KR20150190998 A KR 20150190998A KR 101816617 B1 KR101816617 B1 KR 101816617B1
- Authority
- KR
- South Korea
- Prior art keywords
- gene
- present
- beta
- galactosidase
- cel1
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/649—Biodiesel, i.e. fatty acid alkyl esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The present invention relates to a beta-galactosidase cel1-KG95 gene derived from a black goat rumen microorganism and its use, more specifically, to a novel beta-galactosidase cel1-KG95 gene selected from a black goat rumen microorganism and its protein product To a feed additive, a detergent composition, and a method for producing biofuel.
Description
The present invention relates to a beta-galactosidase cel1-KG95 gene derived from a black goat rumen microorganism and its use, more specifically, to a novel beta-galactosidase cel1-KG95 gene selected from a black goat rumen microorganism and its protein product To a feed additive, a detergent composition, and a method for producing biofuel.
The main constituents of plant cell walls are celluloase, hemi-cellulose, and pectin, which are degraded and absorbed by microorganisms through complex and effective processes in herbivore rumen. Rumen microorganisms are extreme anaerobes, including fungi, protozoa and bacteria, and the breakdown of fibrin is mainly responsible for bacteria and fungi. However, most of these microorganisms are not well known because they are difficult to cultivate. Among the ruminal microorganisms known to date, bacteria that are mainly involved in digesting plant cell walls include Fibrobacter succinogenes), luminometer Caucus Playa Pacifica beret Enschede (Ruminococcus flavefaciens), luminometer Cocu live bus (Ruminococcusalbus), Libby brick Booty avoid debris Sol Bence (Butyrivibrio fibrisolvens), oil cake Te Solarium cellulite with a brush Bence (Eubacterium The bacteria belonging to the genus cellulosolvens), frame Beam telra (Prevotella), and some of Clostridium (Clostridium) have been identified. To date, most microbial DNA in the digestive organs of cows, rabbits, and kangaroos, or the metagenome (referred to as the total DNA of environmental microorganisms) has been studied to identify the most abundant enzymes in the rumen, A number of glucanases and cellulosome complexes have been identified through this process.
However, most of the above cases have evolved from soft fungal fibrinogen to food. In industry, degradation ability of fibrinolytic enzyme to harder fibrin source is required.
Black goats evolved to digest feeds of the less coarse fibrinogen, such as twigs, bark, and vegetation. This means that the ruminal microbial population of the black goat evolved differently from other herbivores. Techniques for searching for novel substances using fosmid, cosmid, and bacterial artificial chromosome (GAC) gene banks have been widely used for gene search for promiscuous microorganisms. In this way, a number of fibrinolytic enzyme genes have been found to date.
Under these technical backgrounds, the present inventors have made intensive efforts to accomplish the present invention.
Finally, it is an object of the present invention to provide a beta-galactosidase cel1-KG95 gene derived from a black goat rumen microorganism and its use.
According to one aspect of the present invention, beta-galactosidase cel1-KG95 gene derived from a black goat rumen microorganism and consisting of the nucleotide sequence shown in SEQ ID NO: 1 can be provided.
According to another aspect of the present invention, GH1 and BGL domain-based beta-galactosidase proteins derived from a black goat rumen microorganism and encoded by the gene and consisting of the amino acid sequence shown in SEQ ID NO: 2 can be provided.
According to another aspect of the present invention, a recombinant vector containing the gene may be provided.
According to another aspect of the present invention, a host cell transformed with the recombinant vector may be provided.
According to another aspect of the present invention, there is provided a feed additive for promoting fibrin degradation comprising the beta-galactosidase protein.
According to another aspect of the present invention, a detergent composition comprising the beta-galactosidase protein can be provided.
According to another aspect of the present invention, there is provided a method for producing a biofuel comprising the step of hydrolyzing a biomass material by adding the beta-galactosidase protein.
The present invention provides a novel chlorine-derived fibrinolytic enzyme capable of degrading a harder fibrin source. By utilizing the present invention, it is possible to develop a low-cost feed additive against the rise in the price of feed grains, develop biofuels using the most abundant resource on the planet, and apply it to various fields such as a fiber softener and a process for adding a cellulose degrading enzyme can do.
FIG. 1 shows the results of meta genome DNA fragment cleavage conditions and insertion DNA cleavage for the construction of the Fosmid gene bank.
Fig. 2 shows the results of confirming the average insertion size of the phosphide gene bank for the Ad fraction and the Lq fraction.
Fig. 3 shows clonal selection results of inoculation on Esculin-Agar plates and the change of the surrounding brown color according to the esculin degradation.
Figure 4 shows nucleotide blast results according to the present invention.
FIG. 5 shows the major domain identification results according to the protein blast according to the present invention.
Figure 6 shows the major analogous proteins according to the protein blast results of the present invention.
FIG. 7 shows the phylogenetic tree and homology of the highest homologous protein and other fibrinolytic enzymes among the protein blast results of the present invention.
Hereinafter, the present invention will be described in more detail.
The term " superfamily " used in the present invention means a group of proteins having similar amino acid sequences, protein functions, and three-dimensional structures of proteins.
The term " biomass " used in the present invention refers to a whole of a biological organism including a plant carrying out a carbon assimilation process for fixing carbon dioxide using sunlight and a living animal eating it. Various fuels such as alcohol, diesel, and hydrogen produced from the biomass are called biofuel, and biomass such as biomass such as cellulose is proposed as a substitute for chemical substances obtained from petroleum . Plant-based biomass is more advantageous in terms of energy balance than petroleum as raw material in producing various chemical products.
The reason for this is that, in the case of the plant-based biomass, various functional groups including oxygen are included, so that it is possible to convert to a lower activation energy when various chemical products with functional groups are produced.
The term 'biofuel' used in the present invention includes all the byproducts derived from metabolism activities such as feces and living organisms as well as fossil fuels. It is a renewable energy different from fossil fuels, and bioethanol and biodiesel And the like.
The present invention focuses on fibrin degrading ability of a black goat rumen microorganism, and constructs a fosmid gene bank against a black goat rumen microorganism metagenome, from which an exocellulase system, beta-glucosidase activity And the plasmid DNA of the clone was decoded to secure the genetic information. The gene encoding Escherichia coli was transformed into Escherichia coli. The plasmid DNA of the active phosmid clone was extracted using the Qiagen Midi Prep Kit, and the extracted DNA produced 100 times more shotgun sequencing data with an average length of 220 bp. Sequence information was obtained in fasta format. The major domain and similar genes were searched for NCBI blastp sequence of the obtained active fosmid plasmid DNA sequence to identify the fibrinolytic enzyme related gene.
The present invention is very different from the recently disclosed fibrinolytic enzyme gene sequence.
According to one aspect of the present invention, beta-galactosidase cel1-KG95 gene derived from a black goat rumen microorganism and consisting of the nucleotide sequence shown in SEQ ID NO: 1 can be provided.
The beta-galactosidase cel1-KG95 gene according to the present invention may be DNA or RNA encoding beta-galactosidase protein. DNA includes cDNA, genomic DNA, or artificial synthetic DNA. The DNA may be single stranded or double stranded. The DNA may be a coding strand or a non-coding strand.
Preferably, the beta galactosidase cel1-KG95 gene according to the present invention may comprise the nucleotide sequence shown in SEQ ID NO: 1. Variants of the above base sequences are also included within the scope of the present invention. More specifically, the gene comprises a nucleotide sequence having a sequence homology of 70% or more, preferably 80% or more, more preferably 90% or more, and most preferably 95% or more, from the nucleotide sequence of SEQ ID NO: 1 .
The 'percentage of sequence homology to polynucleotides' is identified by comparing the comparison region with two optimally aligned sequences, and a portion of the polynucleotide sequence in the comparison region is the reference sequence for the optimal alignment of the two sequences (addition or deletion) (I. E., A gap) relative to the < / RTI >
According to an embodiment of the present invention, the beta galactosidase cel1-KG95 gene may preferably be derived from a black goat rumen microorganism. However, the present invention is not necessarily limited thereto. Examples of the present invention may include high homology (for example, 70% or more, preferably 80% or more, more preferably 90% or more) with the beta galactosidase cel1- , Most preferably at least 95% sequence homology) and may comprise a gene derived from a rumen microorganism of another organism other than a black goat. Methods for sequencing and means for determining sequence homology (e.g., BLAST, etc.) are well known to those skilled in the art.
According to another aspect of the present invention, GH1 and BGL domain-based beta-galactosidase proteins derived from a black goat rumen microorganism and encoded by the gene and consisting of the amino acid sequence shown in SEQ ID NO: 2 can be provided.
The range of the beta-galactosidase protein according to the present invention includes GH1 and BGL domain-based proteins consisting of the amino acid sequence shown in SEQ ID NO: 2 isolated from the black goat rumen microorganism and functional equivalents of the proteins.
The term "functional equivalent" means that at least 70% or more, preferably 80% or more, more preferably 90% or more, or more preferably 90% or more, of the amino acid sequence shown in SEQ ID NO: 2 as a result of addition, 2, and most preferably at least 95%, of the amino acid sequence shown in SEQ ID NO: 2, and has substantially the same physiological activity as the protein consisting of the amino acid sequence shown in SEQ ID NO: 2. The term " substantially homogenous bioactivity " means the same beta galactosidase activity.
The invention also includes fragments, derivatives and analogues of beta-galactosidase proteins. The term "fragments", "derivatives" and "analogues" refer to polypeptides having substantially the same biological function or activity as the beta-galactosidase protein according to the present invention.
Fragments, derivatives and analogs of beta-galactosidase proteins according to the present invention can be obtained by (i) replacing one or more conservative or non-conservative amino acid residues, preferably conservative amino acid residues, (Ii) a polypeptide having a substituent (s) at one or more amino acid residues, or (iii) another compound (a compound capable of prolonging the half-life of the polypeptide (Iii) a polypeptide derived from a mature polypeptide conjugated to a polypeptide, e. G., Polyethylene glycol), or (iv) an additional amino acid sequence (e. G., A leader sequence, a secretory sequence, a sequence used to purify the polypeptide, proteinogen < / RTI > sequence or a fusion protein). The fragments, derivatives and analogs defined in accordance with the present invention are well known to those skilled in the art.
The amino acid sequence represented by SEQ ID NO: 2, that is, the polynucleotide encoding the mature polypeptide, is a coding sequence that encodes only the mature polypeptide; Sequences encoding mature polypeptides and various additional coding sequences; Mature polypeptides (and any additional coding sequences) and sequences coding for noncoding sequences.
The term " polynucleotide encoding the polypeptide " refers to a polynucleotide encoding a polypeptide, or a polynucleotide further comprising additional coding and / or noncoding sequences.
The present invention also relates to variants of said polynucleotides encoding polypeptides comprising the same amino acid sequence as described above, or fragments, analogs and derivatives thereof. Polynucleotide variants can be naturally occurring allelic variants or non-naturally occurring variants. The nucleotide mutant includes a substitution mutant, a deletion mutant, and an insertion mutant.
As is known to those of ordinary skill in the art, an allelic variant is an alternative to a polynucleotide, which may comprise one or more substituted, deleted or inserted nucleotides, Lt; RTI ID = 0.0 > polypeptide < / RTI >
According to another aspect of the present invention, a recombinant vector containing the gene may be provided.
The vector according to the invention can typically be constructed as a vector for cloning or expression. In addition, the vector according to the present invention can be constructed by using prokaryotic cells or eukaryotic cells as hosts. For example, when the vector according to the present invention is an expression vector and a prokaryotic cell is used as a host, a strong promoter (for example, pL promoter, trp promoter, lac promoter, T7 promoter, tac promoter, etc.) , Ribosome binding sites for initiation of detoxification, and transcription / translation termination sequences. When E. coli is used as the host cell, the promoter and operator site of the E. coli tryptophan biosynthesis pathway, and the left-handed promoter of the phage (pL promoter) can be used as a regulatory region.
Herein, the vectors that can be used in the present invention include plasmids (e.g., pSC101, ColE1, pBR322, pUC8 / 9, pHC79, pGEX, pQE80L series, pET series and pUC19, etc.) commonly used in the technical field to which the present invention belongs, (E.g., gt4B, -Charon, z1, and M13) or viruses (e.g., SV40, etc.).
In addition, when the vector according to the present invention is an expression vector and the eukaryotic cell is a host, a promoter derived from the genome of a mammalian cell (e.g., a metallothionine promoter) or a mammalian virus (e.g., Adeno Virus late promoter, vaccinia virus 7.5K promoter, SV40 promoter, cytomegalovirus promoter, and tk promoter of HSV) can be used, and generally have a polyadenylation sequence as a transcription termination sequence.
The vectors according to the present invention may be used as selectable markers and include antibiotic resistance genes commonly used in the art to which the present invention belongs, for example, ampicillin, gentamycin, carbenicillin, chloramphenicol, streptomycin, kanamycin, , ≪ / RTI > neomycin, and tetracycline.
According to another aspect of the present invention, a host cell transformed with the recombinant vector may be provided.
The host cell for stably transforming the vector according to the present invention into a prokaryotic cell and then expressing the vector may be a host cell commonly used in the technical field of the present invention, for example, E. coli JM109 , E. coli BL21 , E. coli RR1 , E. coli LE392 , E. coli B , E. coli X 1776 , E. coli W3110, Bacillus subtilis, and Bacillus thuringiensis, or enterobacteria and strains such as Salmonella typhimurium, Serratia marcesensus and various Pseudomonas spp. Can be used.
When the vector according to the present invention is transformed into eukaryotic cells, yeast ( Saccharomyce cerevisiae ), insect cells, human cells (for example, Chinese hamster ovary, W138, BHK, COS-7, 293, HepG2, 3T3, RIN and MDCK cell lines) and plant cells.
The method of delivering a vector according to the present invention into a host cell can be carried out by the CaCl 2 method, Hanahan, D., J. MoI. Biol., 166: 557-580 (1983) ) And electric drilling method. When the host cell is a eukaryotic cell, the vector can be injected into the host cell by microinjection, calcium phosphate precipitation, electroporation, liposome-mediated transfection, DEAE-dextran treatment, gene bombardment, have.
According to another aspect of the present invention, there is provided a feed additive for promoting fibrin degradation comprising the beta-galactosidase active enzyme protein.
Feed additives according to the present invention include organic acids such as citric acid, fumaric acid, adipic acid, lactic acid and malic acid; Phosphates such as sodium phosphate, potassium phosphate, acid pyrophosphate, polyphosphate (polymerized phosphate) and the like; Natural antioxidants such as polyphenol, catechin, alpha-tocopherol, rosemary extract, vitamin C, green tea extract, licorice extract, chitosan, tannic acid, phytic acid and the like have.
The feed additive according to the present invention may contain adjuvant components such as amino acids, inorganic salts, vitamins, antibiotics, antimicrobials, antioxidants, antifungal enzymes and other microbial agents in the form of live cells; Grain, for example, ground or crushed wheat, oats, barley, corn and rice; Vegetable protein feedstuffs, for example, based on rapeseed, soybeans and sunflower; Animal protein feeds such as blood, meat, bone meal and fish meal; A dry component consisting of sugar and dairy products, for example various powdered milk and whey powders; Lipids such as animal fat and vegetable fat optionally liquefied by heating; Nutritional supplements, digestion and absorption enhancers, growth promoters, disease prevention agents, and the like.
The feed additive according to the present invention may be in the form of a dry or liquid preparation, and may contain an excipient for feed addition. Examples of the excipient for adding the feed include zeolite, corn or rice bran, and the present invention is not limited to the above examples.
The feed additive according to the present invention may be used as an enzyme preparation, for example, a lipase such as lipase, a phytase which decomposes phytic acid to form phosphate and inositol phosphate, starch and glycogen Amylase, which is an enzyme that hydrolyzes the α-1,4-glycoside bond, phosphatase, which is an enzyme that hydrolyzes the organic phosphate ester, and maltose, And a conversion enzyme which hydrolyzes maltase and saccharose to produce a glucose-fructose mixture, and the like.
The feed additive according to the present invention may be administered to animals alone or in combination with other feed additives in edible carriers. The feed additives can also be administered as top dressing or they can be mixed directly with the livestock feed or separately from the feed, in separate oral formulations, or in combination with other ingredients.
A single daily intake or divided daily intake can be used as is commonly known in the art.
The animal in which the feed additive according to the present invention can be used can be, for example, an animal such as a cow, a cow, a calf, a pig, a pig, a sheep, a goat, a horse, a rabbit, a dog, , Poultry such as ducks, geese, turkeys, quails, small birds, and the like, and are not necessarily limited to the above examples.
The amount of beta-galactosidase according to the present invention contained in the feed additive according to the present invention is not particularly limited. However, as is commonly known in the art to which the present invention pertains, In an amount sufficient to decompose the material.
According to another aspect of the present invention, a detergent composition comprising the beta galactosidase active enzyme protein may be provided.
The detergent composition according to the present invention may be in the form of a part and a part of an aqueous detergent composition, a non-aqueous liquid detergent composition, a cast solid, a granular form, a granular form, a compressed tablet, a gel, a paste or a slurry. The detergent composition can be used to quickly remove food stains, food residue films, and other small amounts of food compositions.
The detergent compositions according to the present invention may be effective in removing dried stains through the catalytic-mediated hydrolysis of starch polysaccharides.
The detergent composition according to the present invention may be provided in the form of a detergent composition for cleaning hard surfaces, a detergent composition for cleaning fabrics, a detergent composition for washing dishes, a detergent composition for oral cleaning, a detergent for cleaning denture or a contact lens cleaning solution .
According to another aspect of the present invention, there is provided a method for producing a biofuel comprising the step of hydrolyzing a biosyntactic substance by adding the beta-galactosidase active enzyme protein.
The biomass material according to the present invention is a biomass material containing a high molecular weight carbohydrate. The method for preparing a biofuel according to the present invention comprises: pre-treating a biomass material containing a high molecular weight carbohydrate; Hydrolyzing the pretreated biomass with an enzyme; And a step of fermenting the hydrolyzed biomass material. The method of manufacturing the biofuel may be performed by a method of manufacturing a biofuel commonly known in the art.
In the method for producing a biofuel according to the present invention, the biomass may be selected from the group consisting of starchy (cereals, potatoes), cellulose (herb, wood, chaff) Organic material such as manure, carcass, microbial cells and paper and food waste derived therefrom), and the like, and the present invention is not limited to the above examples.
Hereinafter, the present invention will be described in more detail by way of examples. However, the following examples are illustrative of the present invention and the contents of the present invention are not limited to the following examples.
Example
Isolation and DNA extraction of black goat rumen microorganisms
Two males and one female black goat were raised for only one month with rice straw and mineral supplements, and then slaughtered. The rumen was obtained from the four rumen, and the content was obtained. The obtained contents were first separated into a liquid phase (Lq) and an adherent phase (Ad) by using gauze. Feed scoop Ad was obtained by suspending the residue after filtering with gauze in 0.15% (volume / volume) Tween-80, PBS solution, and recovering the microorganisms attached to rice straw. A total of 5 g of the precipitated sample was prepared and extracted with CTAB (hexadecylmethylammonium bromide) and SDS (sodium dodecyl sulfate).
Black goat rumen microbe fosmid Construction of gene bank
For the DNA extracted from Ad and Lq, the amount of several HindIII restriction enzymes was adjusted for the appropriate truncation conditions to construct a fosmid gene bank. As a result, Ad was determined to use 5 units of HindIII and 2.5 units of Lq (Fig. 1). The partially cleaved DNA fragments were clipped from 10 kb to 50 kb using the Pulse-Field Gel electrophoresis method, from which the insert DNA fragments were again prepared. The prepared DNA was subjected to terminal smoothing reaction and ligated to the pCC1FOS vector by ligation reaction. After the ligation reaction, it was transformed into DH5alpha E. coli by electrical shock method to construct a gene bank. In order to confirm the average insertion size of the constructed fosmid gene bank, NotI enzyme treatment was performed and it was confirmed by electrophoresis that 30 kb for Ad and 31 kb for Lq (FIG. 2). For each of these, 150 plates of 384 well plates were inoculated on cryopreservation media and stored in a cryogenic freezer (-70 ° C).
Esculin ( Esculin ) Decomposing activity Fosmid ( fosmind ) Clone starter
A total of 115,200 clones of Ad and Lq phosphodiester clones were inoculated with 0.5 μl of LB chloramphenicol agar medium containing 1.65% esculin iron substrate in 384 clone units using a VIAFLO 384 instrument from INTEGRA, Time. Clones having the activity of degrading esculin in the cultured plate exhibited a brown color around them, and thus active clones were selected visually (Fig. 3).
Esculin ( Esculin ) Decomposition activity Fosmid Sequence decode for clones
The fosmid plasmid extraction was carried out using the Qiagen plasmid midi prep kit for the phosmid clone Ad_006O06 identified above. The extracted plasmid DNA was averaged 220 bp in length using an Ion Personal Genome Machine (PGM) 100 times more shotgun sequencing data. The resulting data was converted to fasta format and assembled using the Newbler 2.5 de novo assembler program. A total of three consensus sequences were constructed, and a total of 34,870 bp of metagenomic sequence information was obtained with a length of 22,495 bp, 9,103 bp, and 3,272 bp, respectively.
- Sequence Locations: National Livestock Research Institute, RDA
Black goat derived from sequence: Rat three days after birth of two black goats (two males and one female) born in the livestock genetic resource laboratory in the National Livestock Research Institute, RDA. After ruminant diets and mineral supplements, sample
- Fosmid gene bank vector: pCC1Fos
- Genomic Fosmid clone designation: Ad_006O06
- DNA sequence of the gene (SEQ ID NO: 1) Length: 1,356 bp
- amino acid sequence of the gene (SEQ ID NO: 2) length: 451 amino acids
- DNA and protein sequence of the gene:
Gene search and similarity survey
The inserted DNA sequence of fosmid clones was searched for the gene region using the MetaGeneMark program. Regarding the detected gene information, similar sequence information of each gene was obtained primarily through protein blast of NCBI. In this process, a novel fibrinolytic enzyme gene was extracted by referring to the main domain search result and the similar protein. As shown in the nucleotide blast result (Fig. 4) of cel1-KG95 as of October 2015, there is no similar sequence for the entire 1,356 bp gene. In addition, as a result of protein blinding, it was confirmed to have glycosyl hydrolase 1 (
The product of the cel1-KG95 gene, which is a kind of fibrinolytic enzyme beta-galactosidase containing the GH1 domain according to the present invention, can be used not only as a feed additive but also as a detergent and a biofuel, Lt; / RTI >
While the present invention has been particularly shown and described with reference to specific embodiments thereof, those skilled in the art will appreciate that such specific embodiments are merely preferred embodiments and that the scope of the present invention is not limited thereby. something to do. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.
<110> RURAL DEVELOPMENT ADMINISTRATION <120> Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof <130> NPF-29353 <160> 2 <170> PatentIn version 3.2 <210> 1 <211> 1356 <212> DNA <213> unidentified bacterium <400> 1 atgtttcctg cggattttct gtggggcgca gcctgcgccg cctatcagtg cgaaggcgcc 60 tggaatgaag acggcaaggg cctgaacatc tgggatgaat ttacccatgt gccgggccac 120 atcaaaaacg acgataccgg cgacgtggcc tgcgattgct atcaccgctg gcgggaagac 180 gtggccctga tgaagcagtg caggctgcag gcgtatcgct tttccatcag ctgggcccgc 240 attttgcccg atggggacgg ggaagtgaat gaaaaaggct ttgcctttta cgatcatttg 300 gtggatgagc tgatccaaaa cggcattgag cccatgatta ccctgtacca ttgggatttg 360 cccagcgccc tgcaattgcg gggcggctgg ctgaacccgg agatcgaaaa atggtttggc 420 cgatacgccc ggatcatcgg ggagcatttc aagggccggg tcaccaaata catgaccatc 480 aacgagcccc agtgcatcac cgccctgggc tacggcgcgg gggtcatggc gccgggactg 540 caattgccgg aagagcaatt ggcccgcatt taccaccaca tctgcctgtg ccacagcgaa 600 gcccaaaggc aattgaagca ggcgtgcggc gcggatacgc aggtgggcat cgtgccctgc 660 gggaaactgt gcttcccgca gcaggatacg gagcagggcc gggccgccgc atacgacgcc 720 actttccgcc tgggtgaaaa agattgggag ttcaccttca atattgtgct ggacagttttg 780 gtcaatcggt gctatgatgc ttctgcaccg gatgctgtgc gccgttttgc cgccgccatt 840 ccttcatgcg aatgggaacg gatggaaaaa ccggatttca tcggtatcaa tgtataccgg 900 ggagatatgg tggatgcgga gggcaagccc gttcccctgt atcccggcca tccccgcacg 960 gcctgcaaat ggcagatcac cccggaagtg atgcactacg ggcctttgaa cctgtataag 1020 cggtatcatt tgcccctgta catcacggaa aacggcgttt cctgcaacga cgtcattttc 1080 ctggacggcc gggtgcacga tcccgagcgc attgatttcc tggcccggta tattgccgag 1140 ctggggaagg cgctggacga gggcgtgccg gtgaaggggt atctgcaatg gagcttcctg 1200 gataatttcg agtggggctc cggctacaac gagcgctttg gcatcgtata tgtggattac 1260 cgcacacagc agcgcattcc caaggattcc gcccgctggt atgccaattt gatcgcagcc 1320 aacggaaaca atctgaacat ggaggaagaa acatga 1356 <210> 2 <211> 451 <212> PRT <213> unidentified bacterium <400> 2 Met Phe Pro Ala Asp Phe Leu Trp Gly Ala Ala Cys Ala Ala Tyr Gln 1 5 10 15 Cys Glu Gly Ala Trp Asn Glu Asp Gly Lys Gly Leu Asn Ile Trp Asp 20 25 30 Glu Phe Thr His Val Pro Gly His Ile Lys Asn Asp Asp Thr Gly Asp 35 40 45 Val Ala Cys Asp Cys Tyr His Arg Trp Arg Glu Asp Val Ala Leu Met 50 55 60 Lys Gln Cys Arg Leu Gln Ala Tyr Arg Phe Ser Ile Ser Trp Ala Arg 65 70 75 80 Ile Leu Pro Asp Gly Asp Gly Glu Val Asn Glu Lys Gly Phe Ala Phe 85 90 95 Tyr Asp His Leu Val Asp Glu Leu Ile Gln Asn Gly Ile Glu Pro Met 100 105 110 Ile Thr Leu Tyr His Trp Asp Leu Pro Ser Ala Leu Gln Leu Arg Gly 115 120 125 Gly Trp Leu Asn Pro Glu Ile Glu Lys Trp Phe Gly Arg Tyr Ala Arg 130 135 140 Ile Ile Gly Glu His Phe Lys Gly Arg Val Thr Lys Tyr Met Thr Ile 145 150 155 160 Asn Glu Pro Gln Cys Ile Thr Ala Leu Gly Tyr Gly Ala Gly Val Met 165 170 175 Ala Pro Gly Leu Gln Leu Pro Glu Glu Gln Leu Ala Arg Ile Tyr His 180 185 190 His Ile Cys Leu Cys His Ser Glu Ala Gln Arg Gln Leu Lys Gln Ala 195 200 205 Cys Gly Ala Asp Thr Gln Val Gly Ile Val Pro Cys Gly Lys Leu Cys 210 215 220 Phe Pro Gln Gln Asp Thr Glu Gln Gly Arg Ala Ala Ala Tyr Asp Ala 225 230 235 240 Thr Phe Arg Leu Gly Glu Lys Asp Trp Glu Phe Thr Phe Asn Ile Val 245 250 255 Leu Asp Ser Leu Val Asn Arg Cys Tyr Asp Ala Ser Ala Pro Asp Ala 260 265 270 Val Arg Arg Phe Ala Ala Ala Ile Pro Ser Cys Glu Trp Glu Arg Met 275 280 285 Glu Lys Pro Asp Phe Ile Gly Ile Asn Val Tyr Arg Gly Asp Met Val 290 295 300 Asp Ala Glu Gly Lys Pro Val Pro Leu Tyr Pro Gly His Pro Arg Thr 305 310 315 320 Ala Cys Lys Trp Gln Ile Thr Pro Glu Val Met His Tyr Gly Pro Leu 325 330 335 Asn Leu Tyr Lys Arg Tyr His Leu Pro Leu Tyr Ile Thr Glu Asn Gly 340 345 350 Val Ser Cys Asn Asp Val Ile Phe Leu Asp Gly Arg Val Val Asp Pro 355 360 365 Glu Arg Ile Asp Phe Leu Ala Arg Tyr Ile Ala Glu Leu Gly Lys Ala 370 375 380 Leu Asp Glu Gly Val Val Lys Gly Tyr Leu Gln Trp Ser Phe Leu 385 390 395 400 Asp Asn Phe Glu Trp Gly Ser Gly Tyr Asn Glu Arg Phe Gly Ile Val 405 410 415 Tyr Val Asp Tyr Arg Thr Gln Gln Arg Ile Pro Lys Asp Ser Ala Arg 420 425 430 Trp Tyr Ala Asn Leu Ile Ala Ala Asn Gly Asn Asn Leu Asn Met Glu 435 440 445 Glu Glu Thr 450
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150190998A KR101816617B1 (en) | 2015-12-31 | 2015-12-31 | Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150190998A KR101816617B1 (en) | 2015-12-31 | 2015-12-31 | Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170080951A KR20170080951A (en) | 2017-07-11 |
| KR101816617B1 true KR101816617B1 (en) | 2018-01-10 |
Family
ID=59354954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150190998A KR101816617B1 (en) | 2015-12-31 | 2015-12-31 | Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101816617B1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101503860B1 (en) | 2013-06-26 | 2015-03-18 | 대한민국 | cellulase cel45-KG80 gene from rumen microorganism of black goat and uses thereof |
| KR101503856B1 (en) | 2013-06-26 | 2015-03-19 | 대한민국 | xylanase-active enzyme cel10-CBM6-KG60 gene from rumen microorganism of black goat and uses thereof |
-
2015
- 2015-12-31 KR KR1020150190998A patent/KR101816617B1/en active IP Right Grant
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101503860B1 (en) | 2013-06-26 | 2015-03-18 | 대한민국 | cellulase cel45-KG80 gene from rumen microorganism of black goat and uses thereof |
| KR101503856B1 (en) | 2013-06-26 | 2015-03-19 | 대한민국 | xylanase-active enzyme cel10-CBM6-KG60 gene from rumen microorganism of black goat and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170080951A (en) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101503860B1 (en) | cellulase cel45-KG80 gene from rumen microorganism of black goat and uses thereof | |
| KR101503856B1 (en) | xylanase-active enzyme cel10-CBM6-KG60 gene from rumen microorganism of black goat and uses thereof | |
| KR101816600B1 (en) | Beta glucosidase cel3-KG92, cel3-KG93, cel3-KG96 or cel-KG94 gene from rumen microorganism of black goat and uses thereof | |
| KR101816617B1 (en) | Beta galactosidase cel1-KG95 gene from rumen microorganism of black goat and uses thereof | |
| KR101437491B1 (en) | xylanase-active enzyme cel10-CBM6-KG61 gene from rumen microorganism of black goat and uses thereof | |
| KR101816622B1 (en) | O-glycosyl hydrolase cel2-KG97 gene from rumen microorganism of black goat and uses thereof | |
| KR101816615B1 (en) | Alpha amylase cel57-KG91 gene from rumen microorganism of black goat and uses thereof | |
| KR101816620B1 (en) | Endo-1,4-beta-xylanase cel10-KG99 gene from rumen microorganism of black goat and uses thereof | |
| KR102010838B1 (en) | Alpha galactosidase cel36-KG101 gene from rumen microorganism of black goat and uses thereof | |
| KR102019987B1 (en) | Pectinase cel35-KG100 gene from rumen microorganism of black goat and uses thereof | |
| KR101437538B1 (en) | cellulase cel-KG55 gene from rumen microorganism of black goat and uses thereof | |
| KR101437577B1 (en) | cellulase cel-KG27 gene from rumen microorganism of black goat and uses thereof | |
| KR101437588B1 (en) | cellulase cel-KG43 gene from rumen microorganism of black goat and uses thereof | |
| KR101437544B1 (en) | cellulase cel-KG25 gene from rumen microorganism of black goat and uses thereof | |
| KR101437545B1 (en) | cellulase cel-KG36 gene from rumen microorganism of black goat and uses thereof | |
| KR101437589B1 (en) | cellulase cel-KG37 gene from rumen microorganism of black goat and uses thereof | |
| KR101437571B1 (en) | cellulase Cel-KG11 gene from rumen microorganism of black goat and uses thereof | |
| KR101437573B1 (en) | cellulase cel-KG26 gene from rumen microorganism of black goat and uses thereof | |
| KR20180075786A (en) | Amylosucrase AS-KG102 gene from rumen microorganism of black goat and uses thereof | |
| KR101437567B1 (en) | cellulase cel-KG51 gene from rumen microorganism of black goat and uses thereof | |
| KR101437529B1 (en) | cellulase cel-KG48 gene from rumen microorganism of black goat and uses thereof | |
| KR101437548B1 (en) | cellulase cel-KG38 gene from rumen microorganism of black goat and uses thereof | |
| KR101437585B1 (en) | cellulase cel-KG33 gene from rumen microorganism of black goat and uses thereof | |
| KR101437551B1 (en) | cellulase cel-KG45 gene from rumen microorganism of black goat and uses thereof | |
| KR101437562B1 (en) | cellulase cel-KG49 gene from rumen microorganism of black goat and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |